StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) KPIs and segments

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.76+0.25 (+1.22%)

Close on Nov 18, 2026Market cap $158.52MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Bright Minds Biosciences's business

Coming soon

This tab will track the numbers specific to Bright Minds Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?